Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000899243-21-026342

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Carlo Rizzuto Director 2021-06-24 Grant or award · Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/doc4.xml…